These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 26964673

  • 1. Compound profiling and 3D-QSAR studies of hydrazone derivatives with activity against intracellular Trypanosoma cruzi.
    Costa LB, Cardoso MV, de Oliveira Filho GB, de Moraes Gomes PA, Espíndola JW, de Jesus Silva TG, Torres PH, Silva Junior FP, Martin J, de Figueiredo RC, Leite AC.
    Bioorg Med Chem; 2016 Apr 15; 24(8):1608-18. PubMed ID: 26964673
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
    Elizondo-Jimenez S, Moreno-Herrera A, Reyes-Olivares R, Dorantes-Gonzalez E, Nogueda-Torres B, Oliveira EAG, Romeiro NC, Lima LM, Palos I, Rivera G.
    Med Chem; 2017 Apr 15; 13(2):149-158. PubMed ID: 27396731
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and antitrypanosomal profile of new functionalized 1,3,4-thiadiazole-2-arylhydrazone derivatives, designed as non-mutagenic megazol analogues.
    Carvalho SA, da Silva EF, Santa-Rita RM, de Castro SL, Fraga CA.
    Bioorg Med Chem Lett; 2004 Dec 20; 14(24):5967-70. PubMed ID: 15546709
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ligand-based design, synthesis, and experimental evaluation of novel benzofuroxan derivatives as anti-Trypanosoma cruzi agents.
    Jorge SD, Palace-Berl F, Mesquita Pasqualoto KF, Ishii M, Ferreira AK, Berra CM, Bosch RV, Maria DA, Tavares LC.
    Eur J Med Chem; 2013 Jun 20; 64():200-14. PubMed ID: 23644203
    [Abstract] [Full Text] [Related]

  • 8. Studies toward the structural optimization of new brazilizone-related trypanocidal 1,3,4-thiadiazole-2-arylhydrazone derivatives.
    Carvalho SA, Lopes FA, Salomão K, Romeiro NC, Wardell SM, de Castro SL, da Silva EF, Fraga CA.
    Bioorg Med Chem; 2008 Jan 01; 16(1):413-21. PubMed ID: 17904851
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.
    Massarico Serafim RA, Gonçalves JE, de Souza FP, de Melo Loureiro AP, Storpirtis S, Krogh R, Andricopulo AD, Dias LC, Ferreira EI.
    Eur J Med Chem; 2014 Jul 23; 82():418-25. PubMed ID: 24929292
    [Abstract] [Full Text] [Related]

  • 10. New 2-nitroimidazole-N-acylhydrazones, analogs of benznidazole, as anti-Trypanosoma cruzi agents.
    Pitombeira MCSR, Júnior PAS, Murta SMF, Romanha A, Luccas PH, Nonato MC, Rocha REO, Ferreira RS, da Silveira FF, Castelo-Branco FS, Carvalho AS, Boechat N.
    Arch Pharm (Weinheim); 2024 Jul 23; 357(7):e2400059. PubMed ID: 38627301
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and tripanocidal activity of ferrocenyl and benzyl diamines against Trypanosoma brucei and Trypanosoma cruzi.
    Velásquez AM, Francisco AI, Kohatsu AA, Silva FA, Rodrigues DF, Teixeira RG, Chiari BG, de Almeida MG, Isaac VL, Vargas MD, Cicarelli RM.
    Bioorg Med Chem Lett; 2014 Apr 01; 24(7):1707-10. PubMed ID: 24630563
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Novel coumarins active against Trypanosoma cruzi and toxicity assessment using the animal model Caenorhabditis elegans.
    Soares FGN, Göethel G, Kagami LP, das Neves GM, Sauer E, Birriel E, Varela J, Gonçalves IL, Von Poser G, González M, Kawano DF, Paula FR, de Melo EB, Garcia SC, Cerecetto H, Eifler-Lima VL.
    BMC Pharmacol Toxicol; 2019 Dec 19; 20(Suppl 1):76. PubMed ID: 31852548
    [Abstract] [Full Text] [Related]

  • 18. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC, Braga RC, Muratov EN, Franco CH, Moraes CB, Freitas-Junior LH, Andrade CH.
    Eur J Med Chem; 2019 Feb 01; 163():649-659. PubMed ID: 30562700
    [Abstract] [Full Text] [Related]

  • 19. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
    Magalhaes Moreira DR, de Oliveira AD, Teixeira de Moraes Gomes PA, de Simone CA, Villela FS, Ferreira RS, da Silva AC, dos Santos TA, Brelaz de Castro MC, Pereira VR, Leite AC.
    Eur J Med Chem; 2014 Mar 21; 75():467-78. PubMed ID: 24561675
    [Abstract] [Full Text] [Related]

  • 20. Identification of small-molecule inhibitors of Trypansoma cruzi replication.
    Germain AR, Carmody LC, Dockendorff C, Galan-Rodriguez C, Rodriguez A, Johnston S, Bittker JA, MacPherson L, Dandapani S, Palmer M, Schreiber SL, Munoz B.
    Bioorg Med Chem Lett; 2011 Dec 01; 21(23):7197-200. PubMed ID: 22018462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.